[HTML][HTML] Evaluation of immunohistochemical findings and clinical features associated with local aggressiveness in basal cell carcinoma
S ShamsiMeymandi, S Dabiri… - Iranian journal of …, 2019 - ncbi.nlm.nih.gov
Methods: This is a cross-sectional descriptive study conducted on 42 paraffin blocks (22
BCC1, 20 in BCC2) at Pathology Department of Afzalipour Teaching Hospital. First …
BCC1, 20 in BCC2) at Pathology Department of Afzalipour Teaching Hospital. First …
[PDF][PDF] Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non-small cell lung cancer patients
LY He, H Zhang, ZK Wang… - Eur Rev Med Pharmacol …, 2016 - europeanreview.org
OBJECTIVE: To elucidate the re-lationship between E-cadherin (E-cad) and Ki-67, and to
determine their clinical significance in non-small cell lung cancer (NSCLC). PATIENTS AND …
determine their clinical significance in non-small cell lung cancer (NSCLC). PATIENTS AND …
[PDF][PDF] Immunoexpression of p53 and COX-2 in basal cell carcinoma
AO Enache, AE Stepan, C Mărgăritescu… - Rom J Morphol …, 2018 - researchgate.net
Basal cell carcinoma (BCC) is a variety of cutaneous carcinoma associated with an excellent
prognosis because it rarely metastasizes, but it can cause significant local destruction and …
prognosis because it rarely metastasizes, but it can cause significant local destruction and …
Morphometric study of lymphangiogenesis in different lesions of psoriasis vulgaris with correlation to disease activity
N Anis, M Assaf, N Diab, A Soliman… - Journal of Cosmetic …, 2022 - Wiley Online Library
Background and objectives In the last decades, attention to the role of lymphangiogenesis in
psoriasis has been paid. Our study was conducted to evaluate podoplanin‐stained …
psoriasis has been paid. Our study was conducted to evaluate podoplanin‐stained …
Basil cell carcinoma: an immunohistochemical assessment of P53, BCL-2 and CD138 in low and high-risk histological subtypes
J De Stadler - 2023 - open.uct.ac.za
Basal cell carcinoma (BCC) is the leading cancer in males and the second commonest
cancer in females in South Africa. The cost to the health sector is expected to rise given the …
cancer in females in South Africa. The cost to the health sector is expected to rise given the …
[HTML][HTML] Lymphatic Vessel Morphometry: Is It a Predictor for Aggressive Basal Cell Carcinoma?
N Anis, N Diab, M Assaf, A Soliman… - J Clin Aesthet …, 2023 - jcadonline.com
Background. Basal cell carcinoma (BCC) is a locally aggressive skin tumor in which
metastatic spread occurs infrequently, with a predominance of lymphatic involvement. O …
metastatic spread occurs infrequently, with a predominance of lymphatic involvement. O …
Profile of p53 Protein Expression in Basal Cell Carcinoma Low-Risk and High-Risk Subtype
A Chakramurty, MDK Astuti, H Istiadi… - … Medicina: Journal of …, 2022 - bioscmed.com
Background: Basal cell carcinoma is one of the most common cancers in the world, and its
incidence is increasing over time. It is estimated that it accounts for three-quarters of all non …
incidence is increasing over time. It is estimated that it accounts for three-quarters of all non …
Immunohistochemical expression of p53 in basal cell carcinoma of skin.
S Javeed, I Asrar, R Fawad, M Waqar… - The Professional …, 2019 - theprofesional.com
Objectives: To evaluate the immunohistochemical expression of p53 in basal cell carcinoma
of skin. Study Design: It was cross sectional study. Setting: Pathology department of Pakistan …
of skin. Study Design: It was cross sectional study. Setting: Pathology department of Pakistan …
L-amino acid transporter 1 overexpression in nonmelanocytic skin tumors: an immunohistochemical study
AGA Farag, MA Hammam, WA Shehata… - Journal of the …, 2019 - journals.lww.com
Background Despite the low mortality rate of nonmelanoma skin cancer, the associated
morbidity and cost place them as the fifth most expensive cancer to treat. Therefore …
morbidity and cost place them as the fifth most expensive cancer to treat. Therefore …
[PDF][PDF] NGHIÊN CỨU MỨC XÂM LẤN VÀ BỘC LỘ GEN TP53, Ki-67 TRONG UNG THƢ TẾ BÀO ĐÁY VÀ TẾ BÀO VẢY DA ĐẦU MẶT CỔ
NVĂN HÙNG - sdh.hmu.edu.vn
Tôi xin chân thành cảm ơn Ban Giám hiệu, Phòng Đào tạo sau đại học, Bộ môn Ung thư-
Trường Đại học Y Hà Nội, Ban Giám đốc, Phòng Kế hoạch Tổng hợp, Khoa Ngoại Đầu Cổ …
Trường Đại học Y Hà Nội, Ban Giám đốc, Phòng Kế hoạch Tổng hợp, Khoa Ngoại Đầu Cổ …